Latest News

Iktos announces strategic collaboration with Cube biotech

Iktos announces strategic collaboration with Cube biotech

We are thrilled to announce our strategic partnership with Cube Biotech! The synergy between Cube Biotech's advanced membrane protein technology and Iktos' AI-driven drug discovery platform will help us develop novel small molecule agonists of the Amylin Receptor — a target with transformative potential for addressing obesity, diabetes, and other cardiometabolic disorders.

Read the article01.13.2025

Press release

Iktos announces strategic collaboration with Cube biotech
01.13.2025

Iktos announces strategic collaboration with Cube biotech

Iktos appoints new Scientific Advisory Board
10.17.2024

Iktos appoints new Scientific Advisory Board

Iktos announces the acquisition of Synsight
07.08.2024

Iktos announces the acquisition of Synsight

Press articles and news

The future of generative AI and automation in drug discovery

The future of generative AI and automation in drug discovery

Discover the vision of Yann Gaston-Mathé, CEO & Co-Founder of Iktos, on the future of generative AI and automation in drug discovery in this interview from the journal Innovations in Pharmaceutical Technology.

Read the article
Innovations in Pharmaceutical Technology |12.06.2024
The future of generative AI and automation in drug discovery
Innovations in Pharmaceutical Technology | 12.06.2024

The future of generative AI and automation in drug discovery

Iktos wins "Best Digital Innovation" at the Alliancy awards
Alliancy | 12.05.2024

Iktos wins "Best Digital Innovation" at the Alliancy awards

Iktos is one of GEN magazine top picks for AI in Drug Discovery
Genetic Engineering & Biotechnology | 11.29.2024

Iktos is one of GEN magazine top picks for AI in Drug Discovery

Press Kit

Logos
LogosDownload
Photographies
PhotographiesDownload
Contact

Contact

For any communication need please contact our agency.

Ulysse Communication
Mail :  iktosteam@ulysse-communication.com
Tel. : +33663665922